Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic

Introduction: Drug-related problems (DRP) are events or circumstances in which drug therapy does or could interfere with desired health outcomes. In December 2019, a new coronavirus, SARS-CoV-2, appeared. Little knowledge about this type of infection resulted in the administration of various drugs w...

Full description

Bibliographic Details
Main Authors: J. Barceló-Vidal, D. Echeverría-Esnal, N. Carballo, M. De Antonio-Cuscó, X. Fernández-Sala, M. E. Navarrete-Rouco, E. Colominas-González, S. Luque, M. Fuster-Esteva, L. Domingo, M. Sala, X. Duran, S. Grau, O. Ferrández
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Pharmacology
Subjects:
drug-related problem (DRP)
COVID-19
SARS-CoV-2
pharmaceutical care
antiinfective agents
medication related problem
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.993158/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.993158/full

Similar Items